Home > News > OctoPlus secures Euro 18.25 million in second financing round
January 20th, 2005
OctoPlus secures Euro 18.25 million in second financing round
Abstract:
OctoPlus, a drug delivery and development company announced today that it has raised Euro 18.25 million (US$23.85 million) in a second financing round from an international group of investors. The investment was led by Life Sciences Partners II B.V. and S.R. One, Ltd. Other investors participating in this round of financing are Innoven Partenaires, Fortis Private Equity and SurModics, Inc. Fortis Bank acted as OctoPlus' exclusive financial advisor and placement agent in the financing.
Source:
OctoPlus
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||